The utility of short-course radiotherapy in a watch-and-wait strategy for rectal cancer – the need to measure the interval to tumour response assessment from the radiation start

References

• van der Valk MJM, Hilling DE, Bastiaannet E, IWWD Consortium, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the international watch & wait database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–2545.
   PubMed Web of Science ®Google Scholar
• Jia AY, Narang A, Safar B, et al. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma. Radiat Oncol. 2019;14(1):147.
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, São Julião GP, Fernandez LM, et al. Achieving a complete clinical response after neoadjuvant chemoradiation that does not require surgical resection: It may take longer than you think!. Dis Colon Rectum. 2019;62(7):802–808.
   PubMed Web of Science ®Google Scholar
• Hammarström K, Imam I, Mezheyeuski A, et al. Comprehensive evaluation of associations between routinely collected staging information and the response to (chemo)radiotherapy in rectal cancer. Cancers (Basel). 2020;13(1):16.
   PubMed Web of Science ®Google Scholar
• Hupkens BJP, Maas M, Martens MH, et al. Organ preservation in rectal cancer after chemoradiation: Should We extend the observation period in patients with a clinical near-Complete response? Ann Surg Oncol. 2018;25(1):197–203.
   PubMed Web of Science ®Google Scholar
• Jankowski M, Pietrzak L, Rupiński M, Polish Colorectal Study Group, et al. Watch-and-wait strategy in rectal cancer: is there a tumour size limit? Results from two pooled prospective studies. Radiother Oncol. 2021;160:229–235.
   PubMed Web of Science ®Google Scholar
• Kim H, Pedersen K, Olsen JR, et al. Nonoperative rectal cancer management with Short-Course radiation followed by chemotherapy: a nonrandomized control trial. Clin Colorectal Cancer. 2021;20(3):e185–e193.
   PubMed Web of Science ®Google Scholar
• Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40(23):2546–2556.
   PubMed Web of Science ®Google Scholar
• Bujko K, Partycki M, Pietrzak L. Neoadjuvant radiotherapy (5 × 5 Gy): immediate versus delayed surgery. Recent Results Cancer Res. 2014;203:171–187.
   PubMedGoogle Scholar
• Sloothaak DA, Geijsen DE, van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013;100(7):933–939.
   PubMed Web of Science ®Google Scholar
• Probst CP, Becerra AZ, Aquina CT, et al. Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation. J Am Coll Surg. 2015;221(2):430–440.
   PubMed Web of Science ®Google Scholar
• Pettersson D, Lörinc E, Holm T, et al. Tumour regression in the randomized Stockholm III trial of radiotherapy regimens for rectal cancer. Br J Surg. 2015;102(8):972–978.
   PubMed Web of Science ®Google Scholar
• Deacon J, Peckham MJ, Steel GG. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 1984;2(4):317–323.
   PubMed Web of Science ®Google Scholar
• Bujko K, Pietrzak L, Partycki M, et al. The feasibility of short-course radiotherapy in a watch-and-wait policy for rectal cancer. Acta Oncol. 2017;56(9):1152–1154.
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, Perez RO, Wynn G, et al. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum. 2010;53(12):1692–1698.
   PubMed Web of Science ®Google Scholar
• Wawok P, Polkowski W, Richter P, et al. Preoperative radiotherapy and local excision of rectal cancer: Long-term results of a randomised study. Radiother Oncol. 2018;127(3):396–403.
   PubMed Web of Science ®Google Scholar
• Latkauskas T, Pauzas H, Kairevice L, et al. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. BMC Cancer. 2016;16(1):927.
   PubMed Web of Science ®Google Scholar
• Xiao J, Teng W-H, Liu S, et al. Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: comparison of short-term outcomes in patients with T3-4 rectal cancer. Int J Clin Exp Med. 2018;11:12149–12156.
   Web of Science ®Google Scholar
• Bujko K, Wyrwicz L, Rutkowski A, Polish Colorectal Study Group, et al. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol. 2016;27(5):834–842.
   PubMed Web of Science ®Google Scholar
• Bahadoer RR, Dijkstra EA, van Etten B, RAPIDO orative investigators, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42.
   PubMed Web of Science ®Google Scholar
• Jin J, Tang Y, Hu C, et al. Multicenter, randomized, phase III trial of Short-Term radiotherapy plus chemotherapy versus Long-Term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022;40(15):1681–1692.
   PubMed Web of Science ®Google Scholar
• Chakrabarti D, Rajan S, Akhtar N, et al. Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial. Br J Surg. 2021;108(5):511–520.
   PubMed Web of Science ®Google Scholar
• Thakur N, Seam RK, Gupta MK, et al. A prospective observational study comparing Long-Course conventional neoadjuvant chemoradiotherapy with Short-Course radiotherapy followed by consolidation chemotherapy with delayed surgery in locally advanced rectal cancer. South Asian J Cancer. 2020;9(2):80–85.
   PubMed Web of Science ®Google Scholar
• Rombouts AJM, Hugen N, Verhoeven RHA, et al. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients. Eur J Surg Oncol. 2018;44(7):1018–1024.
   PubMed Web of Science ®Google Scholar
• Bach SP; STAR-TREC Collaborative. Can we save the rectum by watchful waiting or TransAnal surgery following (chemo)radiotherapy versus total mesorectal excision for early REctal cancer (STAR-TREC)? protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches. Colorectal Dis. 2022;24(5):639–651.
   PubMed Web of Science ®Google Scholar